Anti-ARHGAP27 antibody (STJA0009547)

SKU:
STJA0009547

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Rho GTPase-activating protein 27 is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: ARHGAP27
Gene ID: 201176
Uniprot ID: RHG27_HUMAN
Specificity: This antibody detects endogenous levels of ARHGAP27 at Human, Mouse, Rat
Immunogen: Synthesized peptide derived from human ARHGAP27
Function Rho GTPase-activating protein which may be involved in clathrin-mediated endocytosis. GTPase activators for the Rho-type GTPases act by converting them to an inactive GDP-bound state. Has activity toward CDC42 and RAC1.
Protein Name Rho Gtpase-Activating Protein 27
Cin85-Associated Multi-Domain-Containing Rho Gtpase-Activating Protein 1
Rho-Type Gtpase-Activating Protein 27
Sh3 Domain-Containing Protein 20
Database Links Reactome: R-HSA-9013148
Reactome: R-HSA-9013149
Cellular Localisation Cytoplasm
Membrane
Peripheral Membrane Protein
Alternative Antibody Names Anti-Rho Gtpase-Activating Protein 27 antibody
Anti-Cin85-Associated Multi-Domain-Containing Rho Gtpase-Activating Protein 1 antibody
Anti-Rho-Type Gtpase-Activating Protein 27 antibody
Anti-Sh3 Domain-Containing Protein 20 antibody
Anti-ARHGAP27 antibody
Anti-CAMGAP1 antibody
Anti-SH3D20 antibody
Anti-PP905 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance